Streetbeat News

Products Services

APM

BREA

CDMO

CERO

LYT

SWIN

Nasdaq rose by 100 points as U.S. stocks traded higher, with BJ's Wholesale reporting weaker than expected sales for Q4 FY23. Materials and health care sectors saw gains, while Lytus Technologies, CERo Therapeutics, and Brera Holdings experienced significant stock increases. Conversely, Solowin Holdings, Aptorum Group, and Express, Inc. saw notable declines. Oil prices fell, while gold and copper prices increased.

Portfolio Pulse from Avi Kapoor

March 07, 2024 | 2:54 pm

MNMD

MindMed shares surged following the FDA's Breakthrough Therapy Designation for its MM120 program in generalized anxiety disorder, coupled with positive 12-week durability data from its Phase 2B study.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:52 pm

CELZ

Creative Medical Technologies has filed four new patent applications covering a range of medical treatments using regenerative cells and adjuvants. These applications focus on reproductive failure, orthopox viruses, space travel-associated bone density loss, and hair loss prevention and treatment.

Portfolio Pulse from Charles Gross

March 07, 2024 | 2:49 pm

ASML

Financial giants have shown a mixed sentiment on ASML Holding (NASDAQ:ASML) with an equal split between bullish and bearish options trades. Analysis of 16 unusual trades revealed 5 puts and 11 calls, indicating a price target range of $730.0 to $1100.0 for the next three months. ASML, a leader in photolithography systems for semiconductor manufacturing, has seen its stock price increase by 1.21%, with a trading volume of 70,163 and an RSI indicating a potential overbought condition. An earnings announcement is expected in 41 days.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 2:46 pm

CODX

Co-Diagnostics, Inc.'s joint venture, CoSara, has received regulatory clearance from Indian authorities for its Influenza Multiplex PCR Test. This approval allows CoSara to market and distribute the test in India, potentially expanding Co-Diagnostics' market presence and revenue streams in the region.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:31 pm

BILI

GAMR

HERO

Bilibili Inc (NASDAQ:BILI) reported Q4 fiscal 2023 revenue of $894.3 million, a 3% increase Y/Y, surpassing consensus estimates. Despite beating EPS estimates with a smaller loss than expected, BILI's stock price dropped. The company saw growth in DAUs, mobile games, and VAS revenues, but a significant decline in IP derivatives and e-commerce revenues. Bilibili ended the year with $2.1 billion in cash. Exposure to BILI can be gained through ETFs like HERO and GAMR.

Portfolio Pulse from Anusuya Lahiri

March 07, 2024 | 2:29 pm

EPOW

EPOW has received an order for 25,000 tons of energy storage materials from Xiamen HiTHIUM Energy Storage Technology Co., Ltd., marking a significant business development for the company.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:26 pm

CYCC

CYCCP

Cyclacel Pharmaceuticals, Inc. announced that preclinical proof-of-concept data for its drug fadraciclib will be presented at the AACR Annual Meeting 2024. The data demonstrates fadraciclib's activity and antitumor effects in various cancers. Fadraciclib, a CDK2/9 inhibitor, has shown promising results in early trials for multiple cancer types. The company is currently conducting a Phase 1/2 trial for fadraciclib in advanced solid tumors and lymphoma.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:24 pm

CELZ

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) announced FDA authorization for CELZ-201, a cell-based therapy aimed at preventing Type 1 Diabetes Mellitus (T1D) in high-risk individuals. This marks a significant advancement in T1D prevention, showcasing CELZ's commitment to innovative healthcare solutions.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 2:23 pm

OND

SOCL

SPOT

Spotify Technology SA (NYSE:SPOT) is raising its subscription fees in France in response to a new 1.2% music tax effective January 1, aimed at supporting the national music sector. This move comes after Spotify's criticism of the tax, which also affects other music streaming services like Apple Music and Google's YouTube Music. Despite a revenue increase in Q4, Spotify's earnings were below consensus. The company's strategy includes price adjustments rather than exiting the French market. Investors can access Spotify through Global X Social Media ETF (NASDAQ:SOCL) and ProShares On-Demand ETF (NYSE:OND).

Portfolio Pulse from Anusuya Lahiri

March 07, 2024 | 2:18 pm